Increased myogenic responses of resistance-sized mesenteric arteries after reduced uterine perfusion pressure in pregnant rats

Hypertension in Pregnancy

Volumn 30, Issue 1, 2011, Pages 45-57

  Ramirez, Rolando J J ^a   Debrah, Julianna ^b   Novak, Jacqueline ^c  

^a UNIVERSITY OF AKRON   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c WALSH UNIVERSITY   (United States)

Author keywords

Arteries; Myogenic; Preeclampsia; Rats; RUPP

Indexed keywords

METHACHOLINE; NITRIC OXIDE; PHENYLEPHRINE; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOGRAPHY; ARTERY PERFUSION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DISEASE MODEL; FETUS WEIGHT; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; NONHUMAN; PHENOTYPE; PREECLAMPSIA; PREGNANCY; PROTEINURIA; RAT; REDUCED UTERINE PERFUSION PRESSURE; RENAL ARTERY; VASOCONSTRICTION; VASODILATATION;

ANIMALS; FEMALE; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; PREGNANCY; PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; UTERUS;

EID: 79952914500     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950903322923     Document Type: Article

References (43)

1. Gammill HS, Roberts JM. Emerging concepts in preeclampsia investigation. Front Biosci 2007; 12:2403-2411.
2. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 2002; 287:3183-3186. (Pubitemid 34686089)
3. Roberts JM, Taylor RN, Goldfien A. Endothelial cell activation as a pathogenetic factor in preeclampsia. Semin Perinatol 1991; 15:86-93.
4. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991; 4:700-708.
5. Roberts L, Lamarca BB, Fournier L, Bain J, Cockrell K, Granger JP. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension 2006; 47:615-618. (Pubitemid 43843885)
6. Ashworth JR, Warren AY, Johnson IR, Baker PN. Plasma from pre-eclamptic women and functional change in myometrial resistance arteries. Br J Obstet Gynaecol 1998; 105:459-461. (Pubitemid 28237876)
7. Pascoal IF Lindheimer MD, Nalbantian-Brandt C, Umans JG. Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest 1998; 101:464-470. (Pubitemid 28067344)
8. Chesley LC. Chesley's Hypertensive Disorders in Pregnancy. In: Lindheimer M, Roberts, JM, Cunningham FG, ed. Stamford, CT: Appleton & Lange, 1999.
9. Crews JK, Herrington JN, Granger JP, Khalil RA. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension 2000; 35:367-372. (Pubitemid 30054201)
10. Alexander BT, Rinewalt AN, Cockrell KL, Massey MB, Bennett WA, Granger JP. Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 2001; 37:485-489. (Pubitemid 32199016)
11. Alexander BT, Bennett WA, Khalil RA. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Amer J Hyperten 2001; 14:178-185S.
12. Lamarca BB, Gilbert J, Granger JP. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension 2008; 51:982-988. (Pubitemid 351398991)
13. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 2007; 50:1142-1147. (Pubitemid 350172938)
14. Gilbert JS, Ryan MJ, Lamarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: Linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008; 294:H541-550. (Pubitemid 351253261)
15. Gilbert J, Dukes M, Lamarca B, Cockrell K, Babcock S, Granger J. Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats. Am J Hypertens 2007; 20:686-691. (Pubitemid 46777259)
16. Anderson CM, Lopez F, Zhang HY, Pavlish K, Benoit Jn. Reduced uteroplacental perfusion alters uterine arcuate artery function in the pregnant Sprague-Dawley rat. Biol Reprod 2005; 72:762-766. (Pubitemid 40279856)
17. Anderson CM, Lopez F, Zhang HY, Shirasawa Y, Pavlish K, Benoit JN. Mesenteric vascular responsiveness in a rat model of pregnancy-induced hypertension. Exp Biol Med (Maywood) 2006; 231:1398-1402. (Pubitemid 44330575)
18. Novak J, Ramirez RJ, Gandley RE, Sherwood OD, Conrad KP. Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats. Am J Physiol Regul Integr Comp Physiol 2002; 283:R349-355. (Pubitemid 34863882)
19. Ramirez RJ, Hubel CA, Novak J, Dicianno JR, Kagan VE, Gandley RE. Moderate ascorbate deficiency increases myogenic tone of arteries from pregnant but not virgin ascorbate-dependent rats. Hypertension 2006; 47:454-460. (Pubitemid 43740290)
20. Novak J, Danielson LA, Kerchner LJ, et al. Relaxin is essential for renal vasodilation during pregnancy in conscious rats. J Clin Invest 2001; 107:1469-1475. (Pubitemid 32522041)
21. Ramirez RJ, Novak J, Johnston TP, Gandley RE, Mclaughlin MK, Hubel CA. Endothelial function and myogenic reactivity in small mesenteric arteries of hyperlipidemic pregnant rats. Am J Physiol Regul Integr Comp Physiol 2001; 281:R1330-R1337.
22. Alexander BT, Llinas MT, Kruckeberg WC, Granger JP. L-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure. Hypertension 2004; 43:832-836. (Pubitemid 38405596)
23. Cockrell KL, Alexander BT, Granger JP, Khalil RA, Crews JK. Decreased endotheliumdependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Amer J Physiol Regulatory Integrat Comparat Physiol 2000; 278:R295-303.
24. Abitbol MM. Simplified technique to produce toxemia in the rat: Considerations on cause of toxemia. Clin Exp Hypertens B 1982; 1:93-103. (Pubitemid 12066049)
25. Rocca B, Loeb Al, Strauss JF, 3rd, et al. Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation. Nature Med 2000; 6:219-221. (Pubitemid 30082370)
26. Llinas MT, Alexander BT, Seedek M, Abram SR, Crell A, Granger JP. Enhanced thromboxane synthesis during chronic reductions in uterine perfusion pressure in pregnant rats. Amer J Hyperten 2002; 15:793-797. (Pubitemid 34970108)
27. Llinas MT, Alexander BT, Capparelli MF, Carroll MA, Granger JP. Cytochrome P-450 inhibition attenuates hypertension induced by reductions in uterine perfusion pressure in pregnant rats. Hypertension 2004; 43:623-628. (Pubitemid 38282438)
28. Lamarca B, Wallukat G, Llinas M, Herse F, Dechend R, Granger JP. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension 2008; 52:1168-1172.
29. Lamarca BD, Alexander BT, Gilbert JS, et al. Pathophysiology of hypertension in response to placental ischemia during pregnancy: A central role for endothelin? Gend Med 2008; 5 Suppl A:S133-S138.
30. Gadonski G, Lamarca BB, Sullivan E, Bennett W, Chandler D, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: Role of interleukin 6. Hypertension 2006; 48:711-716. (Pubitemid 44843876)
31. Ashworth JR, Warren AY, Baker PN, Johnson IR. Loss of endothelium-dependent relaxation in myometrial resistance arteries in pre-eclampsia. Br J Obstet Gynaecol 1997; 104:1152-1158. (Pubitemid 27406486)
32. Pascoal IF, Umans JG. Effect of pregnancy on mechanisms of relaxation in human omental microvessels. Hypertension 1996; 28:183-187. (Pubitemid 26322787)
33. Davidge ST, Baker PN, Roberts JM. NOS expression is increased in endothelial cells exposed to plasma from women with preeclampsia. Am J Physiol 1995; 269:H1106-1112.
34. Davidge ST, Signorella Ap, Hubel Ca, Lykins Dl, Roberts Jm. Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin. Hypertension 1996; 28: 758-764. (Pubitemid 26365515)
35. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol 1997; 272: R441-463.
36. Davidge ST, Hubel CA, Mclaughlin MK. Lipid peroxidation increases arterial cyclooxygenase activity during pregnancy. Amer J Obstet Gynecol 1994; 170:215-222. (Pubitemid 24084057)
37. Davidge ST, Hubel CA, Mclaughlin MK. Cyclooxygenase-dependent vasoconstrictor alters vascular function in the vitamin E-deprived rat. Circul Res 1993; 73:79-88. (Pubitemid 23173058)
38. Davidge ST, Everson WV, Parisi VM, Mclaughlin MK. Pregnancy and lipid peroxide-induced alterations of eicosanoid-metabolizing enzymes in the aorta of the rat. Amer J Obstet Gynecol 1993; 169:1338-1344. (Pubitemid 24001660)
39. Davidge ST. Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reproduct Endocrinol 1998; 16:65-73. (Pubitemid 28285305)
40. Tyurin VA, Liu SX, Tyurina YY, et al. Elevated levels of S-nitrosoalbumin in preeclampsia plasma. Circ Res 2001; 88:1210-1215. (Pubitemid 34132523)
41. Godfrey KM, Barker DJ. Fetal programming and adult health. Public Health Nutr 2001; 4: 611-624. (Pubitemid 32524581)
42. Barker DJ. Fetal origins of cardiovascular disease. Ann Med 1999; 31:3-6. (Pubitemid 29209697)
43. Barker DJ. The malnourished baby and infant. Br Med Bull 2001; 60:69-88. (Pubitemid 34123505)